Published on September 19, 2009 at 2:38 AM
Earlier this week, Eli Lilly & Company (NYSE:LLY) (Indianapolis, Indiana) announced a massive global layoff plan to better fortify the company's defenses against the plagues of profit-killing generics. The grim diagnosis impacts 5,500 employees who will lose their jobs by 2011. Lilly expects to cut $1 billion in expenses by the end of 2011 through the planned job cuts and other measures.
SOURCE: Industrial Info Resources
9bae21a7-f2d2-4f29-934d-96c2353899df|0|.0
Posted in:
Tags: Pfizer